Study explores link between hormonal contraceptives and chronic rhinosinusitis in women

A comprehensive study analyzing data from nearly 240,000 women has found that estrogen-containing hormonal contraceptives are associated with a significantly lower risk of chronic rhinosinusitis ...

Neti pots explained: What they do and how to use them safely

A neti pot is a small teapot-like device – often made of ceramic, plastic or stainless steel – designed “as one way to ...
PharmiWeb

NICE issued final draft guidance recommending dupilumab for eligible severe CRSwNP patients, positioning it to become the first NHS-recommended biologic tre…

The National Institute for Health and Care Excellence (NICE) has published final draft guidance recommending dupilumab as an ...
Hosted on MSN

6 Symptoms of Nasal Polyps — and What You Can Do About Them

You may not be able to see nasal polyps, but that doesn’t mean you can’t sense their constant presence. In fact, more than half of people who have the condition say that reducing or eliminating their ...
Healio

Tezepelumab outperforms other biologics in chronic rhinosinusitis with nasal polyps

Please provide your email address to receive an email when new articles are posted on . The analysis compared results from the WAYPOINT, SINUS-52 and SYNAPSE studies. Tezepelumab outperformed ...
Medical Xpress

Respiratory Tract Diseases: News and Research on Nasal Polyps

U.S. veterans who served in Operation Iraqi Freedom (OIF) and Operation Enduring Freedom (OEF) face an increased risk of developing several chronic respiratory conditions, according to new research ...
Medscape

‘Weed’ Whackers: Biologic Agents Reshaping Nasal Polyp Care

Clinicians have a new line of weapons in their arsenal to treat recurring nasal polyps. Over the past year several new monoclonal antibody-based biologic drugs have been approved to treat the ...
clinicaladvisor.com

Tezspire Gains Approval for Chronic Rhinosinusitis With Nasal Polyps

Findings showed treatment with tezepelumab significantly reduced the size of nasal polyps and nasal congestion compared with placebo. The Food and Drug Administration (FDA) has approved Tezspire ® ...
WebMD

Tezspire: FDA Approves New Option for Chronic Sinus Inflammation With Nasal Polyps

Tezspire (tezepelumab-ekko) is a prescription medicine used to treat inflammatory conditions of the airways, such as severe asthma. The FDA has now approved it as an add-on treatment for adults and ...
The American Journal of Managed Care

Tezepelumab Becomes First TSLP-Targeting Biologic Approved by FDA for CRSwNP

Tezepelumab-ekko is now approved for chronic rhinosinusitis with nasal polyps (CRSwNP), targeting thymic stromal lymphopoietin and marking its second indication after severe asthma. The phase 3 ...
Nasdaq

FDA APPROVES TEZSPIRE® FOR CHRONIC RHINOSINUSITIS WITH NASAL POLYPS

THOUSAND OAKS, Calif., Oct. 17, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) approved TEZSPIRE® (tezepelumab-ekko) for the ...